Direct hemoperfusion with polymyxin B-immobilized fiber improves shock and hypoxemia during endotoxemia in anesthetized sheep

Abstract

This study evaluates the effect of direct hemoperfusion (DHP) using polymyxin B-immobilized fibers (PMX-F) as an extracorporeal blood filter on systemic hypotension and lung injury during endotoxemia. Sheep were anesthetized, intubated, mechanically ventilated with 50% oxygen and connected to the DHP system between the right femoral artery and left jugular vein. Group 1 (n = 6) sheep were infused with 10 μg/kg Escherichia coli endotoxin over a 30 min period. At the same time, sheep underwent DHP with PMX-F (Toraymyxin^®: PMX-20R) for 2 h at a flow rate of 60 ml/h. Group 2 (n = 6) sheep were infused with the same dose of endotoxin and treated with a sham column, in the same manner as those in group 1. DHP with PMX-F significantly improved and restored systemic pressure and arterial oxygen tension in group 1 sheep, although these values never returned to the baseline levels of group 2 sheep. Pulmonary hypertension and leukocytopenia were observed after endotoxin infusion in both groups, but there were no significant differences between these values. DHP with PMX-F significantly decreased the elevation of plasma nitric oxide products. The treatment with PMX-F improves shock and deteriorated oxygenation during endotoxemia, probably through the suppression of nitric oxide production.

References

Kreger BE , Craven DE , McCabe WR Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68: 344—355.

Zilberberg MD , Epstein SK Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med 1998; 157: 1159—1164.

Bone RC , Balk R. , Slotman G. et al. Adult respiratory distress syndrome: sequence and importance of development of multiple organ failure. Chest 1992; 101: 320—326.

Suchyta MR , Clemmer TP , Elliot CG et al. The adult respiratory distress syndrome: a report of survival and modifying factors. Chest 1992; 101: 1074—1079.

Sloane PJ , Gee MH , Gottlieb JE et al. A multicenter registry of patients with acute respiratory distress syndrome. Am Rev Respir Dis 1992; 146: 419—426.

Montgomery AB , Stager MA , Carrio CJ et al. Causes of mortality in patient with the adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132: 485—489.

Seidenfeeld JJ , Pohl DF , Bell RC et al. Incidence, site and outcome of infections in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1986; 134: 12—16.

Bone RC , Mauder R. , Slotman G. et al. An early test of survival in patients with ARDS: the PaO2/FiO2 ratio and its differential response to conventional therapy. Chest 1989; 96: 849—851.

van Deventer SJ , Buller HR , ten Cate JW et al. Endotoxemia: an early predictor of septicaemia in febrile patients. Lancet 1988 ; 2: 605—609.

10.

Ziegler EJ , McCutchan JA , Fierer J. et al. Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1982; 307: 1225—1230.

11.

Artigas A. , Bernard GR , Carlet J. et al. The American—European Consensus Conference on ARDS, Part 2. Am J Respir Crit Care Med 1998; 157: 1332—1347.

12.

Clandra T. , Glauser MP , Schellekens J. et al. Treatment of Gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. J Infect Dis 1988; 158: 312—319.

13.

Bone RC , Balk RA , Fein AM et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med 1995; 23: 994—1006.

14.

Wheeler AP , Hardie WD , Bernard G. Studies of anti-endotoxin antibody in preventing the physiologic changes of endotoxemia in awake sheep. Am Rev Respir Dis 1990; 142: 775—781.

15.

Fischer Jr CJ , Slotman GJ , Opal SM et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. The IL-1 RA Sepsis Syndrome Study Group. Crit Care Med 1994; 22: 12—21.

16.

Cohen J. , Carlet J. INTERSEPT, an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med 1966 ; 24: 1431—1440.

17.

Carraway MS , Welty-Wolf KE , Kantarow SP et al. Antibody to E- and L-selectin does not prevent lung injury or mortality in septic baboons. Am J Respir Crit Care Med 1998; 157: 938—949.

18.

Cheadle WG , Hanasawa K. , Gallinaro RN et al. Endotoxin filtration and immune stimulation improve survival from Gram-negative sepsis. Surgery 1991; 110: 785—791.

19.

Hanasawa K. , Tani T. , Kodama M. New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber. Surg Gynecol Obstet 1989; 168: 323—331.

20.

Aoki H. , Kodama M. , Tani T. et al. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B immobilized fiber. Am J Surg 1994; 167: 412—417.

21.

Takahashi K. Study on quantitative measurement of endotoxin in human blood using chromogenic substrate. J Iwate Med Assoc 1988; 40: 67—68.

22.

Green LC , Wagner DA , Glogowski J. et al. Analysis of nitrate, nitrite, and [15N]-nitrate in biological fluids. Anal Biochem 1982; 126: 131—138.

23.

Rifkind D. , Palmer JD Neutralization of endotoxin toxicity in chick embryos by antibiotics. J Bacteriol 1966; 92: 815—819.

24.

Palmer JD , Rifkind D. Neutralization of the hemodynamic effects of endotoxin by polymyxinB. Surg Gynecol Obstet 1974; 138: 755—759.

25.

Tani T. , Chang Tms , Kodama M. et al. Endotoxin removed from hemoglobin solution using polymyxin-B immobilized fiber (PMX-F) followed by a new turbidometric endotoxin assay . Biomat Art Cells Immob Biotech 1992; 20: 457—462.

26.

Shoji H. , Tani T. , Hanasawa K. et al. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and anti-endotoxin efficacy in the clinical application . Therap Apheresis 1998; 2: 3—12.

27.

Kubo K. , Kobayashi T. Effect of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep. Am Rev Respir Dis 1985; 132: 494—499.

28.

Snapper JR , Bernard GR , Hinson JM et al. Endotoxemia-induced leukopenia in sheep: correlation with lung vascular permeability and hypoxemia but not with pulmonary hypertension. Am Rev Respir Dis 1983; 127: 306—309.

29.

Heflin AC , Brigham KL Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 1981; 68: 1253—1260.

30.

Lamy M. , Fallat JR , Koeniger E. et al. Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. Am Rev Respir Dis 1976; 114: 267—283.

31.

Brigham KL , Kariman K. , Harris TR et al. Lung water and vascular permeability-surface area in humans during acute respiratory failure (Abstract). Am Rev Respir Dis 1980; 121: 426.

32.

Esbenshade AM , Newman JH , Lams PM et al. Respiratory failure after endotoxin infusion in sheep: lung mechanics and lung fluid balance. J Appl Physiol 1982; 53: 967—976.

33.

Obayashi T. , Tamura H. , Tanaka S. et al. A new chromogenic endotoxin-specific assay using recombined Limulus coagulation enzymes and its clinical applications. Clin Chim Acta 1985; 149: 55—65.

34.

Inada K. , Endo S. , Takahashi K. et al. Establishment of a new perchloric acid treatment method to allow detection of the total endotoxin content in human plasma by the Limulus test and clinical application. Microbiol Immunol 1991; 35: 303—314.

35.

Krafte JB , Brilli R. , Szabo C. et al. Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Crit Care Med 1997; 25: 1588—1593.

36.

Mehta S. , Javeshghani D. , Datta P. et al. Porcine endotoxemic shock is associated with increased expired nitric oxide. Crit Care Med 1999; 27: 385—393.

37.

Kilbourn R. Nitric oxide synthase inhibitors — a mechanism-based treatment of septic shock. Crit Care Med 1999 ; 27: 857—858.

38.

SittipuntC. , Steinberg KP , Ruzinski JT et al. Nitric oxide and nitrotyrosinein the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163: 503—510.

39.

Morris Jr SM , Billiar TR New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994; 226: E829—E839.

40.

Fujii Y. , Goldberg P. , Hussain Sna. Contribution of macrophages to pulmonary nitric oxide production in septic shock. Am J Respir Crit Care Med 1998; 157: 1645—1651.

41.

Pheng LH , Francoeur C. , Denis M. The involvement of nitric oxide in mouse model of adult respiratory distress syndrome. Inflammation 1995; 19: 599-601.

42.

Stewart TE , Valenza F. , Ribeiro SP et al. Increased nitric oxide in exhaled gas an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med 1995; 151: 713—718.

43.

Numata M. , Suzuki S. , Miyazawa N. et al. Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J Immunol 1998; 160: 3031—3037.

44.

Hutchison AA , Ogletree ML , Snapper JR et al. Effect of endotoxemia on hypoxic pulmonary vasoconstriction in unanesthetized sheep. J Appl Physiol 1985; 58: 1463—1468.

45.

Roman U. , Kenneth DB , Fumito I. et al. Hypoxic pulmonary blood flow redistribution and arterial oxygenation in endotoxin-challenged NOS2-deficient mice. J Clin Invest 1999; 104: 1421—1429.